共 50 条
- [5] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study [J]. Annals of Hematology, 2017, 96 : 1113 - 1120
- [10] Molecular evidence of JAK2 p.V617F mutated pure erythroid leukemia arising from polycythemia vera [J]. Virchows Archiv, 2018, 473 : 131 - 135